Table of Content

1 Liver Fibrosis Drug Market Introduction and Overview
1.1 Liver Fibrosis Drug Definition
1.2 Research Purposes
1.3 Report Timeline
1.4 Economic Analysis of Global Regions
1.5 Inflation Analysis
1.6 The Impact of the Russian-Ukrainian War on the Market
1.7 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Global Liver Fibrosis Drug Historical Market Analysis by Type
2.1 Market Size Analysis by Types
2.2 Global Liver Fibrosis Drug Revenue and Market Share by Type
3 Global Liver Fibrosis Drug Historical Market Analysis by Application
3.1 Market Size Analysis by Application
3.2 Global Liver Fibrosis Drug Revenue Market Share by Application (2019-2024)
4 Global Market Growth Trends Analysis
4.1 Global Liver Fibrosis Drug Market Size (2019-2024)
4.2 Liver Fibrosis Drug Growth Trends Analysis by Regions
4.2.1 Liver Fibrosis Drug Market Size by Regions: 2019 VS 2024 VS 2030
4.2.2 Liver Fibrosis Drug Historic Revenue Market Size by Regions (2019-2024)
4.2.3 North America Liver Fibrosis Drug Market Size (2019-2024)
4.2.4 Europe Liver Fibrosis Drug Market Size (2019-2024)
4.2.5 Asia-Pacific Liver Fibrosis Drug Market Size (2019-2024)
4.2.6 Latin America Liver Fibrosis Drug Market Size (2019-2024)
4.2.7 Middle East & Africa Liver Fibrosis Drug Market Size (2019-2024)
5 North America
5.1 North America Liver Fibrosis Drug Revenue by Countries
5.1.1 North America Liver Fibrosis Drug Revenue by Countries (2019-2024)
5.2 North America Liver Fibrosis Drug Revenue by Types
5.3 North America Liver Fibrosis Drug Revenue by Applications
5.4 United States
5.5 Canada
6 Asia Pacific
6.1 Asia Pacific Liver Fibrosis Drug Revenue by Countries
6.1.1 Asia Pacific Liver Fibrosis Drug Revenue by Countries (2019-2024)
6.2 Asia Pacific Liver Fibrosis Drug Revenue by Types
6.3 Asia Pacific Liver Fibrosis Drug Revenue by Applications
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Liver Fibrosis Drug Revenue by Countries
7.1.1 Europe Liver Fibrosis Drug Revenue by Countries (2019-2024)
7.2 Europe Liver Fibrosis Drug Revenue by Types
7.3 Europe Liver Fibrosis Drug Revenue by Applications
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Nordic
8 Latin America
8.1 Latin America Liver Fibrosis Drug Revenue by Countries
8.1.1 Latin America Liver Fibrosis Drug Revenue by Countries (2019-2024)
8.2 Latin America Liver Fibrosis Drug Revenue by Types
8.3 Latin America Liver Fibrosis Drug Revenue by Applications
8.4 Brazil
8.5 Argentina
8.6 Mexico
9 Middle East & Africa
9.1 Middle East & Africa Liver Fibrosis Drug Revenue by Countries
9.1.1 Middle East & Africa Liver Fibrosis Drug Revenue by Countries (2019-2024)
9.2 Middle East & Africa Liver Fibrosis Drug Revenue by Types
9.3 Middle East & Africa Liver Fibrosis Drug Revenue by Applications
9.4 Egypt
9.5 South Africa
9.6 UAE
9.7 Turkey
9.8 Saudi Arabia
10 Global Liver Fibrosis Drug Market Competition, by Players
10.1 Global Liver Fibrosis Drug Revenue and Market Share by Players
10.2 Market Concentration Rate
10.2.1 Top 3 Liver Fibrosis Drug Players Market Share in 2023
10.2.2 Top 6 Liver Fibrosis Drug Players Market Share in 2023
10.2.3 Market Competition Trend
10.3 Liver Fibrosis Drug Players Head Office, Business Provided
10.4 Liver Fibrosis Drug Mergers & Acquisitions
10.5 Liver Fibrosis Drug New Entrants and Expansion Plans
11 Players Profiles11.1 Bird Rock Bio Inc.
11.1.1 Bird Rock Bio Inc. Company Profile
11.1.2 Liver Fibrosis Drug Product Overview
11.1.3 Bird Rock Bio Inc. Liver Fibrosis Drug Market Performance (2019-2024)
11.1.4 Bird Rock Bio Inc. Business Overview
11.1.5 Recent Developments and Plans
11.2 Bristol-Myers Squibb Company
11.2.1 Bristol-Myers Squibb Company Company Profile
11.2.2 Liver Fibrosis Drug Product Overview
11.2.3 Bristol-Myers Squibb Company Liver Fibrosis Drug Market Performance (2019-2024)
11.2.4 Bristol-Myers Squibb Company Business Overview
11.2.5 Recent Developments and Plans
11.3 Celgene Corporation
11.3.1 Celgene Corporation Company Profile
11.3.2 Liver Fibrosis Drug Product Overview
11.3.3 Celgene Corporation Liver Fibrosis Drug Market Performance (2019-2024)
11.3.4 Celgene Corporation Business Overview
11.3.5 Recent Developments and Plans
11.4 Dicerna Pharmaceuticals Inc.
11.4.1 Dicerna Pharmaceuticals Inc. Company Profile
11.4.2 Liver Fibrosis Drug Product Overview
11.4.3 Dicerna Pharmaceuticals Inc. Liver Fibrosis Drug Market Performance (2019-2024)
11.4.4 Dicerna Pharmaceuticals Inc. Business Overview
11.4.5 Recent Developments and Plans
11.5 Digna Biotech
11.5.1 Digna Biotech Company Profile
11.5.2 Liver Fibrosis Drug Product Overview
11.5.3 Digna Biotech Liver Fibrosis Drug Market Performance (2019-2024)
11.5.4 Digna Biotech Business Overview
11.5.5 Recent Developments and Plans
11.6 S.L.
11.6.1 S.L. Company Profile
11.6.2 Liver Fibrosis Drug Product Overview
11.6.3 S.L. Liver Fibrosis Drug Market Performance (2019-2024)
11.6.4 S.L. Business Overview
11.6.5 Recent Developments and Plans
11.7 Genfit SA
11.7.1 Genfit SA Company Profile
11.7.2 Liver Fibrosis Drug Product Overview
11.7.3 Genfit SA Liver Fibrosis Drug Market Performance (2019-2024)
11.7.4 Genfit SA Business Overview
11.7.5 Recent Developments and Plans
11.8 Gilead Sciences Inc.
11.8.1 Gilead Sciences Inc. Company Profile
11.8.2 Liver Fibrosis Drug Product Overview
11.8.3 Gilead Sciences Inc. Liver Fibrosis Drug Market Performance (2019-2024)
11.8.4 Gilead Sciences Inc. Business Overview
11.8.5 Recent Developments and Plans
11.9 GNI Group Ltd.
11.9.1 GNI Group Ltd. Company Profile
11.9.2 Liver Fibrosis Drug Product Overview
11.9.3 GNI Group Ltd. Liver Fibrosis Drug Market Performance (2019-2024)
11.9.4 GNI Group Ltd. Business Overview
11.9.5 Recent Developments and Plans
11.10 HEC Pharm Co. Ltd
11.10.1 HEC Pharm Co. Ltd Company Profile
11.10.2 Liver Fibrosis Drug Product Overview
11.10.3 HEC Pharm Co. Ltd Liver Fibrosis Drug Market Performance (2019-2024)
11.10.4 HEC Pharm Co. Ltd Business Overview
11.10.5 Recent Developments and Plans
11.11 Dr. Falk Pharma GmbH
11.11.1 Dr. Falk Pharma GmbH Company Profile
11.11.2 Liver Fibrosis Drug Product Overview
11.11.3 Dr. Falk Pharma GmbH Liver Fibrosis Drug Market Performance (2019-2024)
11.11.4 Dr. Falk Pharma GmbH Business Overview
11.11.5 Recent Developments and Plans
11.12 LG Life Science LTD.
11.12.1 LG Life Science LTD. Company Profile
11.12.2 Liver Fibrosis Drug Product Overview
11.12.3 LG Life Science LTD. Liver Fibrosis Drug Market Performance (2019-2024)
11.12.4 LG Life Science LTD. Business Overview
11.12.5 Recent Developments and Plans
12 Global Liver Fibrosis Drug Forecast Market Analysis by Type
12.1 Global Liver Fibrosis Drug Revenue Market Forecast by Type (2024-2030)
13 Global Liver Fibrosis Drug Forecast Market Analysis by Application
13.1 Liver Fibrosis Drug Revenue Market Forecast by Application (2024-2030)
14 Global Market Growth Forecast Analysis
14.1 Global Liver Fibrosis Drug Forecast Market Size (2024-2030)
14.2 Liver Fibrosis Drug Growth Trends Forecast Analysis by Regions
14.2.1 Liver Fibrosis Drug Revenue Forecast Market Size by Regions (2024-2030)
14.2.2 North America Liver Fibrosis Drug Forecast Market Size (2024-2030)
14.2.3 Europe Liver Fibrosis Drug Forecast Market Size (2024-2030)
14.2.4 Asia-Pacific Liver Fibrosis Drug Forecast Market Size (2024-2030)
14.2.5 Latin America Liver Fibrosis Drug Forecast Market Size (2024-2030)
14.2.6 Middle East & Africa Liver Fibrosis Drug Forecast Market Size (2024-2030)
15 Liver Fibrosis Drug Industry Dynamic Analysis
15.1 Liver Fibrosis Drug Market Trends Analysis
15.2 Liver Fibrosis Drug Market Drivers Analysis
15.3 Liver Fibrosis Drug Market Challenges Analysis
15.4 Liver Fibrosis Drug Market Restraints Analysis